The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AKARI THERAPEUTICS PLC | SPONSORED ADR | 00972G108 | 1,052 | 95,011 | SH | OTR | 1 | 95,011 | 0 | 0 | |
| ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,456 | 291,230 | SH | OTR | 1 | 291,230 | 0 | 0 | |
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 9,093 | 75,000 | SH | OTR | 1 | 75,000 | 0 | 0 | |
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 12,813 | 250,000 | SH | OTR | 1 | 250,000 | 0 | 0 | |
| ANAPTYSBIO INC | COM | 032724106 | 1,388 | 50,000 | SH | OTR | 1 | 50,000 | 0 | 0 | |
| AQUINOX PHARMACEUTICALS INC | COM | 03842B101 | 14,650 | 877,753 | SH | OTR | 1 | 877,753 | 0 | 0 | |
| ARADIGM CORP | COM NO PAR NEW | 038505400 | 893 | 576,208 | SH | OTR | 1 | 576,208 | 0 | 0 | |
| AVEXIS INC | COM | 05366U100 | 78,217 | 1,028,763 | SH | OTR | 1 | 1,028,763 | 0 | 0 | |
| BEIGENE LTD | SPONSORED ADR | 07725L102 | 31,119 | 850,000 | SH | OTR | 1 | 850,000 | 0 | 0 | |
| BELLEROPHON THERAPEUTICS INC | COM | 078771102 | 2,767 | 1,857,143 | SH | OTR | 1 | 1,857,143 | 0 | 0 | |
| BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 30,799 | 770,159 | SH | OTR | 1 | 770,159 | 0 | 0 | |
| CLOVIS ONCOLOGY INC | COM | 189464100 | 63,670 | 1,000,000 | SH | OTR | 1 | 1,000,000 | 0 | 0 | |
| CYMABAY THERAPEUTICS INC | COM | 23257D103 | 3,342 | 777,202 | SH | OTR | 1 | 777,202 | 0 | 0 | |
| EIGER BIOPHARMACEUTICALS INC | COM | 28249U105 | 1,584 | 138,331 | SH | OTR | 1 | 138,331 | 0 | 0 | |
| ESPERION THERAPEUTICS INC NE | COM | 29664W105 | 45,020 | 1,275,000 | SH | OTR | 1 | 1,275,000 | 0 | 0 | |
| INCYTE CORP | COM | 45337C102 | 13,367 | 100,000 | SH | OTR | 1 | 100,000 | 0 | 0 | |
| KURA ONCOLOGY INC | COM | 50127T109 | 4,693 | 533,251 | SH | OTR | 1 | 533,251 | 0 | 0 | |
| LA JOLLA PHARMACEUTICAL CO | COM PAR $.0001 2 | 503459604 | 4,997 | 167,400 | SH | OTR | 1 | 167,400 | 0 | 0 | |
| MEDICINES COMPANY | COM | 584688105 | 59,414 | 1,215,000 | SH | OTR | 1 | 1,215,000 | 0 | 0 | |
| MEDICINES COMPANY | CALL | 584688905 | 33,433 | 683,700 | SH | Call | OTR | 1 | 683,700 | 0 | 0 |
| MIRATI THERAPEUTICS INC | COM | 60468T105 | 5,398 | 1,037,994 | SH | OTR | 1 | 1,037,994 | 0 | 0 | |
| NABRIVA THERAPEUTICS AG | SPONSORED ADR | 62957M104 | 2,121 | 176,710 | SH | OTR | 1 | 176,710 | 0 | 0 | |
| NEXVET BIOPHARMA PUB LTD CO | ORD SHS | G6503X109 | 602 | 154,840 | SH | OTR | 1 | 154,840 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | *W EXP 07/07/202 | 68232V116 | 202 | 241,644 | SH | OTR | 1 | 241,644 | 0 | 0 | |
| ONCONOVA THERAPEUTICS INC | COM NEW | 68232V306 | 962 | 316,386 | SH | OTR | 1 | 316,386 | 0 | 0 | |
| PTC THERAPEUTICS INC | COM | 69366J200 | 14,760 | 1,500,000 | SH | OTR | 1 | 1,500,000 | 0 | 0 | |
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 3,720 | 100,000 | SH | OTR | 1 | 100,000 | 0 | 0 | |
| SEATTLE GENETICS INC | COM | 812578102 | 6,286 | 100,000 | SH | OTR | 1 | 100,000 | 0 | 0 | |
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 4,465 | 940,000 | SH | OTR | 1 | 940,000 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 2,153 | 525,000 | SH | OTR | 1 | 525,000 | 0 | 0 | |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 3,213 | 234,220 | SH | OTR | 1 | 234,220 | 0 | 0 | |